Drug Approval | July 30, 2024
Dr. Reddy's receives positive CHMP opinion from EMA for its proposed Rituximab biosimilar
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
Report highlights significant improvements in adolescent well-being in India
Campaign launched to spread awareness regarding dengue prevention and control
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Laurus Labs has reported total income of Rs. 1,197.42 crores during the period ended June 30, 2024
The inspection was concluded with two 483 observations
This strategic move aims to make Cupid's high-quality products more accessible to consumers nationwide
The product is bioequivalent and therapeutically equivalent to the reference listed drug
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
